Treatment of patients with arterial hypertension and metabolic syndrome. The role of the combination drugs

被引：0
|
作者：
Shilov, A. M. [1 ]
Dulaeva, M. S. [1 ]
Osia, A. O. [1 ]
Lishuta, A. S. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2014年 / 10卷 / 01期
关键词：
arterial hypertension; combination therapy; fixed-dose drug combination; enalapril; lercanidipine;
D O I：
10.20996/1819-6446-2014-10-1-92-98
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented. Advantages and indications for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from prospective studies on the efficacy and safety of combination of third generation calcium channel blocker lercanidipine with ACE inhibitor enalapril are presented.
引用
收藏
页码：92 / 98
页数：7
相关论文
共 50 条
  • [41] Arterial hypertension and obstructive sleep apnoea syndrome: treatment resistance and the role of autonomic dysfunction
    Rostorotskaya, V. V.
    Elgardt, I. A.
    Ivanov, A. P.
    Sdobnyakova, N. S.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (05): : 11 - 17
  • [42] Mental disorders in patients with arterial hypertension with metabolic disturbances
    Petukhov, OI
    Tsygankov, BD
    Zadionchenko, VS
    Khrulenko, SB
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2002, 102 (08): : 8 - 13
  • [43] Role of magnesium in pathogenesis and treatment of arterial hypertension
    Martynov, AI
    Ostroumova, OD
    Mamaev, VI
    Sharkova, NE
    Pochechueva, MV
    TERAPEVTICHESKII ARKHIV, 1999, 71 (12) : 67 - 69
  • [44] Metabolic syndrome in patients with peripheral arterial disease
    Estirado, E.
    Lahoz, C.
    Laguna, F.
    Garcia-Iglesias, F.
    Gonzalez-Alegre, M. T.
    Mostaza, J. M.
    REVISTA CLINICA ESPANOLA, 2014, 214 (08): : 437 - 444
  • [45] Role of atrial natriuretic peptide in the development of arterial hypertension in patients with pubertal hypothalamic syndrome
    Krivchenko T.P.
    Verbovaya N.I.
    Neuroscience and Behavioral Physiology, 1998, 28 (4) : 435 - 437
  • [46] Combination therapy is a new standard for treatment of pulmonary arterial hypertension
    Avdeev, S. N.
    Tsareva, N. A.
    Gaisin, I. R.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (03) : 72 - 80
  • [47] The role of telmisartan in the treatment of metabolic syndrome
    Mychka, V. B.
    Duishvili, D. E.
    Mamyrbaeva, K. M.
    Masenko, V. P.
    Chazova, I. E.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (08) : 63 - 66
  • [48] Arterial hypertension and metabolic syndrome in small indigenous people of the North of Yakutia
    Sofronova, S., I
    YAKUT MEDICAL JOURNAL, 2018, (01): : 14 - 17
  • [49] Physiopathological Mechanisms of Association between Metabolic Syndrome and Arterial Hypertension: an Update
    Franco, Luis Enrique Jimenez
    Perez, Dianelys Maria Gutierrez
    Regal, Milagros Lisset Leon
    Martinez, Claudia Gonzalez
    Leyva, Lucia Banos
    Olivero, Arionnis Matos
    FINLAY, 2023, 13 (01): : 7 - 9
  • [50] Complex correction of vascular hemostasis in patients with arterial hypertension, metabolic syndrome, and recent ocular vessel occlusion
    Medvedev, I. N.
    DaniIenko, O. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2010, (04): : 15 - 19
12345